LAMASSU BIOTECH WELCOMES DR. SAMIR JOHNA AS A CLINICAL ADVISOR

05/16/2024

Esteemed Surgeon and Researcher Brings Decades of Experience to Drive Innovation in Biopharmaceuticals

(CLEVELAND, OH) – Lamassu BioTech is thrilled to announce the addition of Dr. Samir Johna, MD, MACM, FACS, FICS, to its team as a Clinical Advisor. Dr. Johna brings a wealth of experience and expertise that will be invaluable in advancing Lamassu’s mission of pioneering innovative treatments and improving patient care.

Dr. Johna is the founding director of the Arrowhead/Kaiser Permanente General Surgery Residency Program in California, a Clinical Professor of Surgery at Loma Linda University School of Medicine, and a Professor of Surgery at the Bernard Tyson Kaiser Permanente School of Medicine. He has a prolific background in research, having published over 75 peer-reviewed articles in medical journals. He has also authored three books and contributed to several medical texts.

“Joining Lamassu as a clinical advisor is an exciting opportunity to participate in the world of using cutting-edge technology to create new medications. This is a unique chance to bring my clinical experience to help scientists translate their efforts into new treatments. Our goal is to help patients and serve mankind,” said Dr. Johna.

Dr. Johna had led clinical trial studies, and chaired on the IRB of Arrowhead Regional Medical Center (Institutional Review Board). In addition to his medical and academic accomplishments, Dr. Johna is the founder and president of “Without Borders,” a non-profit organization providing free medical care worldwide.

“We are incredibly excited to have Dr. Johna join our team,” said Gabi Hanna, CEO and co-founder of Lamassu BioTech. “His vast experience and dedication to both clinical practice and research make him an exceptional addition to Lamassu. Dr. Johna’s passion for improving healthcare and his compassionate approach to alleviating patient suffering are truly contagious. His insights and expertise will significantly contribute to our ongoing efforts to innovate and accelerate the
biopharmaceutical field.”

Dr. Samir Johna was born in Abu-Ghraib, Baghdad, Iraq. In 1991, he left Iraq for Jordan and then moved to California, where he completed his general surgery residency program in 1998 and became board-certified in 2000.

In 2002, Dr. Johna received an honorary degree and was named a fellow of the American College of Surgeons. He joined the teaching ranks at Loma Linda University, eventually achieving the rank of Clinical Professor of Surgery. In 2013, he completed a Master’s degree in Academic Medicine at USC.

Beyond his medical and scientific experience, Dr. Johna is a poet, having written several books of poetry in Arabic and English. His first book of Assyrian poetry was recently published in Sydney, Australia.

###

ABOUT LAMASSU BIOTECH
Accelerating treatment means saving more lives. At Lamassu, our team of dedicated physicians, engineers, and translational scientists, are driven by a passion to treat patients like family. Our goal is to speed up the innovation process by bringing transformational treatments from concept to bedside faster than other companies. Lamassu!s patient-centric approach to research focuses on making advancements that address unmet needs with novel and targeted strategies, ensuring greater efficiency and shorter approval timeframes. With decades of experience developing leading medical treatments, we believe that it is not only the transformative power of science, but also hope that leads to healing. Learn more at LamassuBioTech.com

READ MORE

05/16/2025

LAMASSU BIOTECH COLLABORATES WITH THE OHIO STATE UNIVERSITY TO STUDY NEW THERAPY FOR MAN AND MAN’S BEST FRIEND

Pioneering Research Will Help Drive Dual-Purpose Treatment for Life-Threatening Conditions in Both Humans and Man’s Best Friend (CLEVELAND, OH) – Man’s best friend may soon benefit from a new treatment, thanks to a new collaboration between Lamassu Biotech and The...

02/07/2025

LAMASSU BIOTECH SET TO ATTEND LEAP 2025

International Conference in Saudi Arabia An Opportunity to Highlight Synergy BetweenTechnology and Medicine (CLEVELAND, OH) — Lamassu Biotech, a pioneering biotechnology company dedicated to developing breakthrough treatments for challenging diseases, will attend LEAP 2025, the premier global technology conference in...

05/16/2024

INNOVATIVE CANCER RESEARCH FIRM LAMASSU BIOTECH ANNOUNCES NEW CORPORATE OFFICES IN CLEVELAND

Lamassu Recently Earned Prestigious NIH Grant and Won FDA Approval to Trial Potentially Transformative Treatment for Metastatic Cancers (CLEVELAND, OH) – One of the pharmaceutical industry’s most leading-edge companies, Lamassu Biotech is proud to announce the establishment of new corporate...